KLRAKailera Therapeutics, Inc.
$12.85
$12.85
$9.9852 weeks$26.00
What is the market doing?
Mixed
1 neutral, 2 without dataModerately shorted. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Short interest6.7% of sharesFINRA · Sep 30, 2026
Moderately shorted, settled Sep 30, 2026, about a week of normal trading to cover. Up 46% since the previous count, up from 3.9% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How KLRA is trading
- Below its 52-week high
- 51%
Below its 52-week high
Details›
- Last close2026-10-23
- $12.85
- 1 monthS&P 500 −0.94%
- +7.3%
- 52-week high
- $26.00
- 52-week low
- $9.98
- Annualised volatility
- 75%
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry